Surrogate analysis of vancomycin to predict susceptible categorization of dalbavancin.
about
Use of vancomycin as a surrogate for dalbavancin in vitro susceptibility testing: results from the DISCOVER studiesDalbavancin: A Novel Lipoglycopeptide Antibiotic with Extended Activity Against Gram-Positive Infections.Dalbavancin: A Review in Acute Bacterial Skin and Skin Structure Infections.Lipoglycopeptide Antibacterial Agents in Gram-Positive Infections: A Comparative Review.New Gram-Positive Agents: the Next Generation of Oxazolidinones and Lipoglycopeptides.Dalbavancin for the treatment of paediatric infectious diseases.Single-Dose Dalbavancin: A Review in Acute Bacterial Skin and Skin Structure Infections.Emerging Resistance, New Antimicrobial Agents … but No Tests! The Challenge of Antimicrobial Susceptibility Testing in the Current US Regulatory Landscape.Dalbavancin Activity When Tested against Streptococcus pneumoniae Isolated in Medical Centers on Six Continents (2011 to 2014).A Reference Broth Microdilution Method for Dalbavancin In Vitro Susceptibility Testing of Bacteria that Grow Aerobically.The role of dalbavancin in the multi-disciplinary management of wound infections in orthopaedic surgery.
P2860
Q35315952-3FC1E6B7-DB71-4BDB-9A2D-8453DD9C69C7Q36073405-081C6CA9-D8F1-4B43-878E-56754EA49D32Q38536284-F433794B-72DA-41BA-A59D-8F900750F81CQ38646905-676DF888-8664-4809-B18D-368A4BA501A3Q38768071-888F8602-CD4C-40EC-AA30-7FEEF01EFAFFQ38937430-10A62D67-8D7A-4575-8D94-4949944E07ACQ39042375-FFF27834-833B-432A-8ABC-CDDE24BFB12AQ39879703-EADBFAA4-2F6D-44F1-BF5A-3892160BE496Q40746046-BFE1689A-24D4-44D3-AB30-3D2A9C48ED29Q40993969-7375995D-ED55-4F8C-ABDB-D3DEFCACD3D2Q48247125-BD17F405-F2D9-430E-9712-F3D70B6BE474
P2860
Surrogate analysis of vancomycin to predict susceptible categorization of dalbavancin.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Surrogate analysis of vancomycin to predict susceptible categorization of dalbavancin.
@en
type
label
Surrogate analysis of vancomycin to predict susceptible categorization of dalbavancin.
@en
prefLabel
Surrogate analysis of vancomycin to predict susceptible categorization of dalbavancin.
@en
P2093
P1476
Surrogate analysis of vancomycin to predict susceptible categorization of dalbavancin.
@en
P2093
David J Farrell
Michael W Dunne
Rodrigo E Mendes
Ronald N Jones
P356
10.1016/J.DIAGMICROBIO.2015.01.017
P577
2015-02-07T00:00:00Z